By Business/Source
Currency:USD
2025/FY
2025/FY
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/FY
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/FY
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/FY
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/FY
2021/Q4
2021/Q3
2021/Q2
2021/Q1
2020/FY
2020/Q4
2020/Q3
2020/Q2
2019/FY
2018/FY
2017/FY
2016/FY
Stock NameRevenueRatio
Develops, manufactures and markets products for the treatment of carotid artery disease and other8.98M100.00%
By Country/Region
Currency:USD
2025/FY
2025/FY
2024/FY
2023/FY
2022/FY
2021/FY
2020/FY
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2015/Q4
2015/Q3
2015/Q2
2015/Q1
2014/FY
2014/Q4
2014/Q3
2014/Q2
2014/Q1
2013/FY
2014/Q1
2013/FY
2013/Q2
2013/Q1
Stock NameRevenueRatio
Other4.06M45.23%
USA1.42M15.78%
Germany1.23M13.73%
Italy1.23M13.72%
Poland1.04M11.54%